http://proteases-inhibitors.co....m/occurrence-predict
Level a few severe or chronic lung adverse effects were observed in up to 30% of patients that received WLI after HD treosulfan/Mel (HD-Treo/Mel) or HD etoposide (E)/Mel. Interstitial pneumonitis was contained in 9% of clients treated concurrently with E/Mel and complete human anatomy irradiation (TBI) with 8 Gy. Radiation doses also time taken between HD-Cth and WLI were both recognized as significant danger facets for pulmonary purpose problems. CONCLUSION The risk of adverse lung